Our results indicated a decrease of crotonate in plasma from IBD patients, and crotonate supplementation effectively alleviated experimental colitis via the ACSS2‐H4K12cr‐CLDN7 axis. The gene discussed is CLDN7; the disease is inflammatory bowel disease.